- Home
- SUPN vs CUBI Comparison
SUPN vs CUBI Comparison
Compare SUPN & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- CUBI
- Stock Information
- Founded
- SUPN 2005
- CUBI 1994
- Country
- SUPN United States
- CUBI United States
- Employees
- SUPN N/A
- CUBI N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- CUBI Major Banks
- Sector
- SUPN Health Care
- CUBI Finance
- Exchange
- SUPN Nasdaq
- CUBI Nasdaq
- Market Cap
- SUPN 2.6B
- CUBI 2.2B
- IPO Year
- SUPN 2012
- CUBI 2012
- Fundamental
- Price
- SUPN $47.92
- CUBI $65.81
- Analyst Decision
- SUPN Buy
- CUBI Strong Buy
- Analyst Count
- SUPN 2
- CUBI 8
- Target Price
- SUPN $51.50
- CUBI $74.50
- AVG Volume (30 Days)
- SUPN 682.2K
- CUBI 318.7K
- Earning Date
- SUPN 11-03-2025
- CUBI 10-30-2025
- Dividend Yield
- SUPN N/A
- CUBI N/A
- EPS Growth
- SUPN 1411.53
- CUBI N/A
- EPS
- SUPN 1.14
- CUBI 4.05
- Revenue
- SUPN $665,125,000.00
- CUBI $596,459,000.00
- Revenue This Year
- SUPN $6.71
- CUBI $16.37
- Revenue Next Year
- SUPN $19.74
- CUBI $6.49
- P/E Ratio
- SUPN $42.23
- CUBI $16.19
- Revenue Growth
- SUPN 5.55
- CUBI N/A
- 52 Week Low
- SUPN $29.16
- CUBI $40.75
- 52 Week High
- SUPN $49.66
- CUBI $72.51
- Technical
- Relative Strength Index (RSI)
- SUPN 66.02
- CUBI 47.44
- Support Level
- SUPN $47.34
- CUBI $63.76
- Resistance Level
- SUPN $49.66
- CUBI $66.99
- Average True Range (ATR)
- SUPN 1.23
- CUBI 1.70
- MACD
- SUPN -0.08
- CUBI -0.23
- Stochastic Oscillator
- SUPN 66.70
- CUBI 32.70
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.